The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s neuroscience antibodies and assays market report forecasts the neuroscience antibodies and assays market size to grow to $6.24 Billion by 2027, with a CAGR (compound annual growth rate) of more than 11%.

Learn More On The Neuroscience Antibodies And Assays Market Report 2023 – https://www.thebusinessresearchcompany.com/report/neuroscience-antibodies-and-assays-global-market-report

Neuroscience Antibodies And Assays Market Size Forecast
The global neuroscience antibodies and assays market is expected to grow from $3.6 billion in 2022 to $4.04 billion in 2023 at a compound annual growth rate (CAGR) of 12.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The neuroscience antibodies & assays market size is expected to grow to $6.24 billion in 2027 at a CAGR of 11.5%.

North America held the largest neuroscience antibodies and assays market share.

Key Neuroscience Antibodies And Assays Market Driver ­– Increase In Incidents Of Neurological Illnesses Across The Globe
For instance, According to the World Health Organization, a Switzerland-based health promotion agency 55 million people live with dementia globally, and there are nearly 10 million new cases every year as per 2021 data. According to Alzheimer’s Association a US based Non-profit association, 6.5 million people in the US have Alzheimer’s disease as per 2022 data. As a result, the increased incidence of neurological illnesses across the world is driving the neuroscience antibodies and assays market forward.

Request for A Sample Of The Global Neuroscience Antibodies And Assays Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7548&type=smp

Key Neuroscience Antibodies And Assays Market Trend – Technological Advancement
Major companies operating in the market are introducing new technologies such as Cisbio HTRF® that works on TR-FRET technology to sustain their position in the market. For instance, in October 2020, PerkinElmer Inc., a US-based diagnostics, life sciences, and environmental research company, launched ‘PerkinElmer Cisbio HTRF® Phospho-Ubiquitin (Ser65) Cellular Kit’. The new kit has applications in various disease areas such as Alzheimer’s and Parkinson’s disease. The novel assays can be applied to increase study specificity for the Phospho-Ubiquitin (Ser65) intersection point. With the help of TR-FRET technology helps to identify crucial mitophagy dysfunction and breakdowns in the intricate network between neurons and glial cells that can result in neurodegenerative disease.

Neuroscience Antibodies And Assays Market Segment
1) By Product: Consumables, Instruments
2) By Technology: Molecular Diagnostics, Clinical Chemistry, Immunoassays Or Immunochemistry, Others Technologies
3) By Application: In Vitro Diagnostics, Research, Drug Discovery
4) By End User: Hospitals And Diagnostics Centers, Academic And Research Institutes, Pharmaceutical And Biotechnology Companies

Neuroscience Antibodies And Assays Market Major Players and Strategies
Major players in the neuroscience antibodies and assays market are Abcam PLC, BioLegend Inc., Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., F. Hoffmann-La Roche AG, GenScript Biotech Corporation, Merck KGaA, Rockland Immunochemicals Inc., Santa Cruz Biotechnology Inc., Siemens Healthineers, Tecan Group Ltd., Thermo Fisher Scientific Inc., and Enzo Life Sciences AG.

In June 2022, Fujirebio, a Japanese multinational biotechnology company, acquired ADx NeuroSciences for an undisclosed amount. With this acquisition, Fujirebio will be able to provide neurodegenerative disease diagnostic solutions at the global level. ADx Neurosciences is a Belgium-based developer of neurodegenerative biomarkers and specialized in developing tailor-made antibodies and assays for pharma and in vitro diagnostics companies.

The Neuroscience Antibodies And Assays Global Market Report 2023 covers regional data on neuroscience antibodies and assays market size, neuroscience antibodies and assays market trends and drivers, opportunities, strategies, and neuroscience antibodies and assays market competitor analysis. The countries covered in the neuroscience antibodies and assays market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The neuroscience antibodies & assays are used to study the development, systems, structure and function, disorders, and degeneration of the nervous system. Neuroscience is the study of the nervous system, its working, and diseases related to the nervous system. Antibodies and assays is a medical test that is based on principles of interaction between antigenic epitopes and antibodies, and this test is useful in neuroscience and the study of neurological disorders.

View More Reports Related To The Neuroscience Antibodies And Assays Market –
Neuroscience Global Market Report 2023
Neurology Devices Global Market Report 2023
Neurostimulation Devices Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: